Observations on the effects of buprenorphine and methadone on illicit drug use
DOI:
https://doi.org/10.5055/jom.0861Keywords:
agonistic effects, buprenorphine, methadone, urine drug testingAbstract
Objective: To determine if the agonistic effects of buprenorphine and methadone affect drug use.
Method: Quantitative examination of urine drug concentrations of patients treated with buprenorphine and methadone.
Results: Patients on buprenorphine had less opioid and methamphetamine drug use than those on methadone.
Conclusion: Patients on buprenorphine therapy appear to use less illicit drugs.
References
US Department of Veterans Affairs: VA/DoD clinical practice guidelines. 2021. Available at https://www.healthquality.va.gov/guidelines/mh/sud/. Accessed April 29, 2024.
Amadeo P, Raymond S, Dennis R, et al.: Effects of a pandemic and isolation on alcohol and psychoactive medication use in a population of rehabilitation and pain patients annals of clinical & laboratory science. Ann Clin Lab Sci. 2021; 51(5): 694-697.
Krock, K, Pesce A, Ritz D, et al.: Lower cutoff for LC-MS/ MS urine drug testing indicates better patient compliance. Pain Physician. 2017; 20: E1107-E1113. DOI: https://doi.org/10.36076/ppj/2017.7.E1107
Pesce AJ, Chandler N, Ackerman G: Information technology structure for urine drug testing reports 21ST century pathology 2021 21CP-1-103.pdf. Available at 21stcenturypathology.com. Accessed April 29, 2024.
Vigezzi P, Guglielmino L, Marzorati P, et al.: Multimodal drug addiction treatment: A field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients. J Subst Abuse Treat. 2006; 31: 3-7. DOI: https://doi.org/10.1016/j.jsat.2006.03.007
Montoya ID, Gorelick DA, Preston KL, et al.: Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther. 2004; 75(1): 34-48. DOI: 10.1016/j.clpt.2003.09.004. DOI: https://doi.org/10.1016/j.clpt.2003.09.004
Furo H, Wiegand T, Rani M, et al.: Association between buprenorphine dose and the urine “norbuprenorphine” to “creatinine” ratio: Revised. Subst Abuse. 2023; 17: 117822182311537. DOI: 10.1177/11782218231153748. DOI: https://doi.org/10.1177/11782218231153748
Furo H, Schwartz DG, Sullivan RW, et al.: Buprenorphine dosage and urine quantitative buprenorphine, norbuprenorphine, and creatinine levels in an office-based opioid treatment program. Subst Abuse. 2021; 15: 11782218211061749. DOI: https://doi.org/10.1177/11782218211061749
Downloads
Published
How to Cite
Issue
Section
License
Copyright 2005-2024, Weston Medical Publishing, LLC
All Rights Reserved
